You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-MMP13 antibodySee all MMP13 primary antibodies ...
  • Description
    Rabbit polyclonal to MMP13
  • Specificityab39012 recognizes the latent proenzyme, at 60 Kd, as well as the active form at 48 Kd, and intermediate activation forms. It does not cross react with the other MMP family members.
  • Tested applicationsIHC-Fr, IHC-P, WB, ICC/IF, Sandwich ELISA more details
  • Species reactivity
    Reacts with: Mouse, Rat, Dog, Human
  • Immunogen

    Synthetic peptide based on the hinge region of human MMP13.

    (Peptide available as ab44853.)

  • Epitopeab39012 recognizes the Hinge region of MMP13.
  • Positive controlcell media from human chondrosarcoma (IL1 beta treated).

Properties

Applications

Our Abpromise guarantee covers the use of ab39012 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC-Fr IHC-Fr: 1/200.
IHC-P IHC-P: Use at an assay dependent dilution.
WB WB: 1/3000 - 1/6000. Predicted molecular weight: 54 kDa.Can be blocked with MMP13 peptide (Hinge Region) (ab44853). 1/3000, when using colorimetric substrates such as BCIP/NBT - 1/6000, when using chemiluminescent substrates. Dilution optimised using Chromogenic detection. When used against the reduced protein identifies a band at 60 Kd. Note: The low endogenous protein levels may require concentration of samples by ultrafiltration or ammonium sulfate precipitation prior to Western blotting.
ICC/IF ICC/IF: Use at an assay dependent concentration.
Sandwich ELISA sELISA: Use a concentration of 0.5 µg/ml. Can be paired for Sandwich ELISA with Mouse monoclonal [181-15A12] to MMP13 (ab77949). For sandwich ELISA, use this antibody as Detection at 0.5µg/ml with Ab77949 as Capture.

Target

  • FunctionDegrades collagen type I. Does not act on gelatin or casein. Could have a role in tumoral process.
  • Tissue specificitySeems to be specific to breast carcinomas.
  • Involvement in diseaseDefects in MMP13 are the cause of spondyloepimetaphyseal dysplasia Missouri type (SEMD-MO) [MIM:602111]. A bone disease characterized by moderate to severe metaphyseal changes, mild epiphyseal involvement, rhizomelic shortening of the lower limbs with bowing of the femora and/or tibiae, coxa vara, genu varum and pear-shaped vertebrae in childhood. Epimetaphyseal changes improve with age.
    Defects in MMP13 are the cause of metaphyseal anadysplasia type 1 (MANDP1) [MIM:602111]. Metaphyseal anadysplasia consists of an abnormal bone development characterized by severe skeletal changes that, in contrast with the progressive course of most other skeletal dysplasias, resolve spontaneously with age. Clinical characteristics are evident from the first months of life and include slight shortness of stature and a mild varus deformity of the legs. Patients attain a normal stature in adolescence and show improvement or complete resolution of varus deformity of the legs and rhizomelic micromelia.
  • Sequence similaritiesBelongs to the peptidase M10A family.
    Contains 4 hemopexin-like domains.
  • DomainThe conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
  • Cellular localizationSecreted > extracellular space > extracellular matrix.
  • Target information above from: UniProt accession P45452 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      CLG 3 antibodyCLG3 antibodyCLG3 antibody
      Collagenase 3 antibodyCollagenase 3 antibodyCollagenase3 antibodyMANDP1 antibodyMatrix metallopeptidase 13 (collagenase 3) antibodyMatrix Metalloproteinase 13 antibodyMatrix Metalloproteinase 13 antibodyMatrix metalloproteinase-13 antibodyMMP 13 antibodyMMP-13 antibodyMmp13 antibodyMMP13_HUMAN antibody
    see all

Anti-MMP13 antibody images

  • Standard curve for MMP13; dilution range 1pg/ml to 1µg/ml using Capture Antibody Mouse monoclonal [181-15A12] to MMP13 (ab77949) at 1µg/ml and Detector Antibody Rabbit polyclonal to MMP13 - Hinge region (ab39012) at 0.5µg/ml.
  • All lanes : Anti-MMP13 antibody (ab39012) at 1/3000 dilution

    Lane 1 : cell media from human chondrosarcoma (untreated).
    Lane 2 : cell media from human chondrosarcoma (IL1 beta treated).


    Predicted band size : 54 kDa
    Observed band size : 60 kDa (why is the actual band size different from the predicted?)
  • ab39012 staining MMP13 in Mouse endochondral precursor (rib cartilage) tissue by Immunohistochemistry (Frozen sections). The sections were PFA-fixed prior to blocking with 10% serum for 1 hour at 19°C. The primary antibody was diluted 1/200 and incubated with the sample for 16 hours at 4°C. An Alexa Fluor® 647-conjugated Donkey anti-Rabbit polyclonal was used as the secondary antibody, diluted 1/200. DAPI was used for the blue counterstain.

    See Abreview

  • Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human colon carcinoma tissue, staining MMP13 with ab39012.

    Tissue was fixed with formaldehyde and blocked with 1% serum for 1 hour at 24°C; antigen retrieval was by heat mediation in a citrate buffer (pH 6). Samples were incubated with primary antibody (1/100 in diluent) for 12 hours at 4°C. A biotinylated goat anti-rabbit polyclonal IgG (1/200) was used as the secondary antibody.

    See Abreview

References for Anti-MMP13 antibody (ab39012)

This product has been referenced in:
  • Eisenbarth SC  et al. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484:510-3 (2012). Read more (PubMed: 22538615) »
  • Dranse HJ  et al. Genetic deletion of Cyp26b1 negatively impacts limb skeletogenesis by inhibiting chondrogenesis. J Cell Sci 124:2723-34 (2011). Read more (PubMed: 21807937) »

See all 5 Publications for this product

Product Wall

Displaying 1 - 9 of 9 results for Abreviews and Q&A

Application Immunocytochemistry/ Immunofluorescence
Sample Rat Cell (rat vascular smooth muscle cells)
Specification rat vascular smooth muscle cells
Fixative Methanol
Permeabilization No
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: 24°C
Username

Verified customer

Submitted Feb 06 2013

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Human Tissue sections (colon carcinoma)
Specification colon carcinoma
Fixative Formaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: citrate buffer (pH 6.0)
Permeabilization No
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 1% · Temperature: 24°C
Username

Verified customer

Submitted Feb 05 2013

Thank you for contacting us and your interest in our products. As discussed over the phone, I have checked the concentration of the antibodies and lot numbers you provided. The concentrations are as follows:

ab52897, GR5286-6, 0.165 mg/ml;
Read More

Thank you for your inquiry.

Are the gel percentages, compositions and running conditions (time, buffer, etc)the same for both WBs? Are you casting your own gels or buying them pre-made? Have you run a WB with both the cell lysates and medium on ...

Read More

Thank you for your inquiry.

Unfortunately, we are not able to release the immunogen sequence for this particular antibody as it is proprietary information.

We aim to provide as much information as possible to our customers, so I am sorry...

Read More
Application Western blot
Sample Rat Cell lysate - whole cell (rat vascular smooth muscle cells)
Loading amount 100000 cells
Specification rat vascular smooth muscle cells
Gel Running Conditions Reduced Denaturing
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 20°C
Username

Verified customer

Submitted Jul 31 2012

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Human Tissue sections (Colon Carcinoma)
Specification Colon Carcinoma
Fixative Formaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Citrate pH 6
Permeabilization No
Blocking step (agent) for 5 minute(s) · Concentration: .25% · Temperature: 25°C
Username

Verified customer

Submitted Nov 28 2011

Application Immunohistochemistry (Frozen sections)
Sample Mouse Tissue sections (Endochondral precursor (rib cartilage))
Specification Endochondral precursor (rib cartilage)
Fixative Paraformaldehyde
Permeabilization Yes - 0.1% Triton
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: 19°C
Username

Verified customer

Submitted Jan 18 2011

Application Western blot
Sample Human Tissue lysate - whole (human aortic extract)
Loading amount 30 µg
Specification human aortic extract
Gel Running Conditions Reduced Denaturing
Blocking step BSA as blocking agent for 16 hour(s) and 0 minute(s) · Concentration: 1% · Temperature: 4°C
Username

Verified customer

Submitted Jan 26 2008

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"